E8 Pharmaceuticals, LLC v. Affymetrix, Inc., No. 13-1046 (Fed. Cir. Nov. 6, 2013)
From the Opinion
The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.
We affirm the judgment of noninfringement in favor of Affymetrix, Inc. and Navigenics, Inc. We base our decision solely on our agreement with the district court’s construction of the phrase “randomly primed PCR-derived RCG.” We do not reach any other issues raised on appeal. AFFIRMED
Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error